News Image

Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million

Provided By GlobeNewswire

Last update: Jan 7, 2025

Company Believes it is Well Positioned for Mid-Term and Long-Term Growth as
Current Capacity Continues to Support up to $300 Million in Annual Revenue

Read more at globenewswire.com

LIFECORE BIOMEDICAL INC

NASDAQ:LFCR (7/3/2025, 11:52:24 AM)

7.995

-0.04 (-0.56%)



Find more stocks in the Stock Screener

Follow ChartMill for more